ArticleTargeted oncology2023

Real-World Treatment Outcomes of MET Exon14 Skipping in Non-small Cell Lung Cancer: GFPC 03-18 Study.

Hélène Babey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.